Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products
Clinical trial NCT05010174 · TERMINATED
Trial details
- NCT number
- NCT05010174
- Sponsor
- Medeor Therapeutics, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-11
- Primary completion
- 2024-04-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.